Aspen Wealth Strategies’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$278K Buy
3,210
+9
+0.3% +$862 0.15% 78
2025
Q4
$307K Buy
3,201
+13
+0.4% +$1.26K 0.17% 70
2025
Q3
$304K Buy
3,188
+291
+10% +$26.8K 0.17% 73
2025
Q2
$253K Buy
2,897
+159
+6% +$13.5K 0.15% 75
2025
Q1
$246K Sell
2,738
-47
-2% -$4.21K 0.16% 76
2024
Q4
$222K Sell
2,785
-102
-4% -$8.83K 0.14% 77
2024
Q3
$260K Buy
+2,887
New +$243K 0.17% 75

Other funds holding MDT

Aspen Wealth Strategies's MDT Position: Q1 2026 in Review

Aspen Wealth Strategies increased its Medtronic (MDT) stake by 0.28% in Q1 2026, buying an estimated $862 and bringing the position to 3,210 shares worth $278K. The position accounts for 0.15% of the portfolio, ranked #78.

Aspen Wealth Strategies first reported a position in MDT in Q3 2024 and has held it in 7 quarters since. The position peaked at $307K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Aspen Wealth Strategies held 3,210 shares of Medtronic worth $278K as of Q1 2026.
  • Aspen Wealth Strategies bought 9 Medtronic shares in Q1 2026, an estimated $862.
  • Medtronic made up 0.15% of Aspen Wealth Strategies's portfolio in Q1 2026, its #78 holding.
  • Aspen Wealth Strategies first reported a position in Medtronic in Q3 2024 and has held it in 7 quarters since.
  • Aspen Wealth Strategies's Medtronic position peaked at $307K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Aspen Wealth Strategies's 13F filing for Q1 2026, filed 8 May 2026.